Cargando…
Correction: Tanguturi et al. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. Molecules 2021, 26, 6693
Autores principales: | Tanguturi, Parthasaradhireddy, Pathak, Vibha, Zhang, Sixue, Moukha-Chafiq, Omar, Augelli-Szafran, Corinne E., Streicher, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954426/ https://www.ncbi.nlm.nih.gov/pubmed/35335399 http://dx.doi.org/10.3390/molecules27061969 |
Ejemplares similares
-
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2021) -
The role of opioid receptors in modulating Alzheimer’s Disease
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2023) -
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial
por: Jacob, Laurent, et al.
Publicado: (2020) -
Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells
por: Li, Yonghe, et al.
Publicado: (2016) -
Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
por: Gangrade, Abhishek, et al.
Publicado: (2018)